July 12, 2023
3M has encouraged a Minnesota federal magistrate judge to stick to his decision not to remove himself from an MDL concerning the company's post-surgery patient warming device despite his once having owned 3M stock and his wife's engagement with the company, waving away the plaintiffs' objections as mere "gamesmanship."
July 10, 2019
3M Co. urged a Minnesota federal court Wednesday to deny a sanctions bid by lead attorneys representing patients in multidistrict litigation over the company's post-surgery patient warming device, saying the move amounts to retaliation against 3M's own attempt to hold them in contempt for revealing sealed documents.
June 14, 2019
Three attorneys accused by 3M Co. of sharing confidential information have urged a Minnesota federal court to not hold them in contempt, arguing the Minnesota-based company failed to substantiate its claims against them in multidistrict litigation over a post-surgery patient warming device.
June 06, 2019
3M Co. asked a Minnesota federal court Thursday to hold in contempt the lead attorneys representing patients in multidistrict litigation over the company's post-surgery patient warming device, saying the attorneys filed a document in a related state court action that revealed information from documents the federal court had sealed.
December 18, 2018
The past year was a lively one on the multidistrict litigation docket as major MDLs over the opiate crisis and the Equifax data breach got up and running, while cases concerning a Monsanto weedkiller and a common hospital technology revved for early bellwether trials.
April 10, 2017
About 30 bellwether cases have been identified in multidistrict litigation over 3M's post-surgery patient-warming device and its alleged tendency to cause infections after orthopedic surgeries, the patients and 3M told a Minnesota federal court Friday.
December 14, 2015
Patients who claim they suffered infections because of 3M's post-surgical patient warming device had their suits sent to Minnesota federal court on Friday, creating multidistrict litigation for the dozens of suits the company has called a smear campaign by a competitor.